Gene · 4173
Papers2,283
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,283
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of AlissAID system targeting GFP or mCherry fusion protein. | PLoS Genet | 2023 | 37315088 | PubTator, text mining | PubMed |
| Testis cell pyroptosis mediated by CASP1 and CASP4: possible sertoli cell-only syndrome pathogenesis. | Reprod Biol Endocrinol | 2023 | 37296437 | PubTator, text mining | PubMed |
| Compilation and functional classification of telomere length-associated genes in humans and other animal species. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 37293446 | PubTator, text mining | PubMed |
| APOBEC3B coordinates R-loop to promote replication stress and sensitize cancer cells to ATR/Chk1 inhibitors. | Cell Death Dis | 2023 | 37270643 | PubTator, text mining | PubMed |
| MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma. | J Cell Mol Med | 2023 | 37246638 | PubTator, text mining | PubMed |
| Saponins of North Atlantic Sea Cucumber: Chemistry, Health Benefits, and Future Prospectives. | Mar Drugs | 2023 | 37233456 | PubTator, text mining | PubMed |
| Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer. | Sci Rep | 2023 | 37231064 | PubTator, text mining | PubMed |
| The FBXO32/ATR/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37227155 | PubTator, text mining | PubMed |
| EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4. | Hereditas | 2023 | 37198697 | PubTator, text mining | PubMed |
| De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residues. | Hum Genet | 2023 | 37198333 | PubTator, text mining | PubMed |
| SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer. | Cancers (Basel) | 2023 | 37190199 | PubTator, text mining | PubMed |
| High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia. | Transl Cancer Res | 2023 | 37180663 | PubTator, text mining | PubMed |
| Association of Mutations in Replicative DNA Polymerase Genes with Human Disease: Possible Application of Drosophila Models for Studies. | Int J Mol Sci | 2023 | 37175782 | PubTator, text mining | PubMed |
| Knockdown of ASF1B inhibits cell proliferation, migration, invasion and cisplatin resistance in gastric cancer through the Myc pathway. | Oncol Lett | 2023 | 37153049 | PubTator, text mining | PubMed |
| Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling. | Int J Biol Sci | 2023 | 37151882 | PubTator, text mining | PubMed |
| The assembly of the MCM2-7 hetero-hexamer and its significance in DNA replication. | Biochem Soc Trans | 2023 | 37145026 | PubTator, text mining | PubMed |
| Replisome dysfunction upon inducible TIMELESS degradation synergizes with ATR inhibition to trigger replication catastrophe. | Nucleic Acids Res | 2023 | 37144518 | PubTator, text mining | PubMed |
| Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection. | J Hepatocell Carcinoma | 2023 | 37128594 | PubTator, text mining | PubMed |
| Bromodomain protein BRD8 regulates cell cycle progression in colorectal cancer cells through a TIP60-independent regulation of the pre-RC complex. | iScience | 2023 | 37123243 | PubTator, text mining | PubMed |
| RAD51 bypasses the CMG helicase to promote replication fork reversal. | Science | 2023 | 37104614 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4173/papers?page=9